,21 Within the lung, LOXL2 is highly expressed within fibroblastic foci, the sites of active fibrogenesis,22 while elevated LOXL2 levels in serum have been associated with increased risk for IPF disease progression in two cohorts of patients.23 This evidence concerns the gene LOXL2 and idiopathic pulmonary fibrosis.